Polydex Pharmaceuticals Ltd (POLXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 01/31
(Values in U.S. thousands)
| 01-2023 | 01-2022 | 01-2021 | 01-2020 | 01-2019 | |
| Sales | 4,405 | 4,229 | 4,856 | 5,141 | 4,943 |
| Cost of Goods | 4,193 | 3,976 | 3,886 | 4,097 | 4,015 |
| Gross Profit | 212 | 253 | 970 | 1,044 | 928 |
| Operating Expenses | 1,169 | 1,717 | 1,646 | 839 | 747 |
| Operating Income | -764 | -488 | 210 | 303 | 196 |
| Interest Expense | 33 | 37 | 43 | 49 | 39 |
| Other Income | 33 | 37 | 43 | -2 | 13 |
| Pre-tax Income | -764 | -488 | 210 | 252 | 170 |
| Income Tax | 2 | 64 | -2 | 2 | -61 |
| Net Income Continuous | -766 | -552 | 212 | 251 | 231 |
| Net Income | $-766 | $-552 | $212 | $251 | $231 |
| EPS Basic Total Ops | -0.22 | -0.16 | 0.06 | 0.07 | 0.07 |
| EPS Basic Continuous Ops | -0.22 | -0.16 | 0.06 | 0.07 | 0.07 |
| EPS Diluted Total Ops | -0.22 | -0.16 | 0.06 | 0.07 | 0.07 |
| EPS Diluted Continuous Ops | -0.22 | -0.16 | 0.06 | 0.07 | 0.07 |
| EPS Diluted Before Non-Recurring Items | -0.22 | -0.16 | 0.06 | 0.07 | 0.07 |
| EBITDA(a) | $-403 | $-121 | $543 | $624 | $511 |